As of 2024-12-14, the Relative Valuation of ChemoCentryx Inc (CCXI) is (50.73) USD. This relative valuation is based on P/E multiples. With the latest stock price at 51.99 USD, the upside of ChemoCentryx Inc based on Relative Valuation is -197.6%.
The range of the Relative Valuation is (52.00) - (52.22) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 27.9x - 39.8x | 34.8x |
| Forward P/E multiples | 19.3x - 28.0x | 19.6x |
| Fair Price | (52.00) - (52.22) | (50.73) |
| Upside | -200.0% - -200.5% | -197.6% |
| Date | P/E |